Programme
ICR Centenary Conference8-10th June 2009 Cancer Genes: Discovery and Exploitation |
| MONDAY 8th JUNE | TUESDAY 9th JUNE | WEDNESDAY 10th JUNE |
Registration and Coffee | Session 2 | Session 4 |
Welcome & Introduction | Tea & Coffee | Tea & Coffee |
KEYNOTE LECTURE | Session 3 | Session 4 |
Lunch and Poster Session | Lunch and Poster Session | Lunch and Poster Session |
Session 1 | Session 3 | Session 4 |
Tea & Coffee | Tea & Coffee | Closing Remarks |
Session 1 | Session 3 | |
KEYNOTE LECTURE | ||
Drinks Reception and Poster Session |
ICR Centenary Conference Monday 8th June 2009 |
10.00 – 10.45 | Registration and Coffee | |
10.45 – 11.30 | Welcome & Introduction | |
11.30 – 12.30 | KEYNOTE LECTURE - Curing cancer | |
12.30 – 14.00 | LUNCH and POSTER SESSION | |
14.00 – 15.45 | ||
14.00 – 14.35 | Patterns of somatic mutation in human cancer genomes Discussion | |
14.35 – 15.10 | Molecular analysis of circulating tumour cells to direct cancer therapies | |
15.10 – 15.45 | Insertional mutagenesis: a potent oncogenomic tool to unravel the genetics of cancer | |
15.45 – 16.15 | Tea and Coffee | |
16.15 – 18.00 SESSION 1: Discovering Cancer Genes (continued) | ||
16.15 – 16.45 | Dissecting tumour suppressor gene networks in vivo Discussion | |
16.50 – 17.20 | Finding biomarkers of drug resistance through functional genetic screens Discussion | |
17.25 – 17.55 | The epigenome of cancer cells Discussion | |
ICR Centenary Conference Tuesday 9th June 2009 |
09.00 – 11.15 SESSION 2: Discovering Cancer Predisposition Genes | ||
09.00 – 09.35 | Genetic susceptibility to cancer - breast cancer and prostate cancer as paradigms Discussion | |
09.35 – 10.10 | Genome-wide association analyses and beyond - teasing out the causes of common cancers Discussion | |
10.10 – 10.45 | Genetic networks and control of cancer susceptibility Discussion | |
10.45 – 11.15 | Cancer predisposition genes - from cause to clinic Discussion | |
11.15 – 11.45 | Tea and Coffee | |
11.45 – 13.00 | ||
11.45 – 12.20 | Clonal evolution in childhood leukaemia Discussion | |
12.20 – 13.00 | Stem cell concepts renew cancer research Discussion | |
13.00 – 14.00 | LUNCH and POSTER SESSION | |
14.00 – 15.45 | ||
14.00 – 14.35 | Chaperoning cancer - protein kinase activation by the Hsp90 molecular chaperone system Discussion | |
14.35 – 15.10 | Studying tumour evolution in mouse models of cancer Discussion | |
15.10 – 15.45 | Synthetic lethal strategies for exploiting DNA repair defects in cancer Discussion | |
15.45 – 16.15 | Tea and coffee | |
16.15 – 18.00 | ||
16.15 – 16.50 | Functions of p53 in metabolism and invasion Discussion | |
16.50 – 17.25 | Insights into the molecular machinery of Rho GTPase activation Discussion | |
17.25 – 18.00 | Translating molecular interactions to functional cancer imaging Discussion | |
18.00 – 19.00 | KEY NOTE LECTURE Discussion Chair: Chris Marshall, The Institute of Cancer Research | |
19.00 – 20.00 | DRINKS RECEPTION and POSTER SESSION | |
ICR Centenary Conference Wednesday 10th June 2009 |
09.00 – 10.45 | ||
09.00 – 09.35 | Zen and the art of genome maintenance: from Ku to KuDOS Discussion | |
09.35 – 10.10 | Bcl-2 family inhibitors for the treatment of cancer Discussion | |
10.10 – 10.45 | BRAF in human cancer: biology and therapeutics Discussion | |
10.45 – 11.15 | Tea and Coffee | |
11.15 – 13.00 | ||
11.15 – 11.50 | Feedback and redundancy in oncoprotein-activated signalling pathways - basic and therapeutic implications Discussion | |
11.50 – 12.25 | Novel approaches to anti-androgen therapy Discussion | |
12.25 – 13.00 | Accelerating anticancer drug development by rational trial design Discussion | |
13.00 – 14.30 | LUNCH and POSTER SESSION | |
14.30 – 16.15 | ||
14.30 – 15.05 | Limited drug distribution and repopulation as important and neglected causes of drug resistance in solid tumours Discussion | |
15.05 – 15.40 | Targeting PI3 kinase in the clinic Discussion | |
15.40 – 16.15 | Drugging the cancer genome: towards personalised molecular medicine Discussion | |
16.15 – 16.30 | Closing remarks Discussion | |
